Nonsteroidal anti-inflammatory drugs (NSAIDs) are a drug class that reduce pain, decrease fever, prevent blood clots and, in higher doses, decrease inflammation. Side effects depend on the specific drug, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack and kidney disease.

Market Analysis and Insights: Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market

The global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Covers:

This report presents an overview of global market for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) revenue, projected growth trends, production technology, application and end-user industry.

Market Segmentation

Scope of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Report

Report Metric	Details
Report Name	Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market
CAGR	5%
Segment by Type	Aspirin Ibuprofen Naproxen Celecoxib Others
Segment by Application	Drug Store Hospital Pharmacies Online
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche (Genentech), Amgen, B-MS, Merck, Pfizer, Novartis, Eli Lilly and Company, Johnson & Johnson, GSK, Sanofi, Boehringer Ingelheim, Zhejiang Jiuzhou Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market report?

Ans: The main players in the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market are Roche (Genentech), Amgen, B-MS, Merck, Pfizer, Novartis, Eli Lilly and Company, Johnson & Johnson, GSK, Sanofi, Boehringer Ingelheim, Zhejiang Jiuzhou Pharmaceutical

What are the Application segmentation covered in the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market report?

Ans: The Applications covered in the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market report are Drug Store, Hospital Pharmacies, Online

What are the Type segmentation covered in the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market report?

Ans: The Types covered in the Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market report are Aspirin, Ibuprofen, Naproxen, Celecoxib, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030

1.2.2 Aspirin

1.2.3 Ibuprofen

1.2.4 Naproxen

1.2.5 Celecoxib

1.2.6 Others

1.3 Market by Application

1.3.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030

1.3.2 Drug Store

1.3.3 Hospital Pharmacies

1.3.4 Online

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Perspective (2019-2030)

2.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Trends by Region

2.2.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Region (2019-2024)

2.2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Region (2025-2030)

2.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Dynamics

2.3.1 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Trends

2.3.2 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers

2.3.3 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges

2.3.4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Players

3.1.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2019-2024)

3.1.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Players (2019-2024)

3.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Ranking by Revenue, 2022 VS 2023 VS 2024

3.4 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio

3.4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2023

3.5 Global Key Players of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Head office and Area Served

3.6 Global Key Players of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Product and Application

3.7 Global Key Players of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Type

4.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Type (2019-2024)

4.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2025-2030)

5 Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Breakdown Data by Application

5.1 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Application (2019-2024)

5.2 Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2019-2030)

6.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type

6.2.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2019-2024)

6.2.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2025-2030)

6.2.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2019-2030)

6.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

6.3.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2019-2024)

6.3.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2025-2030)

6.3.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2019-2030)

6.4 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country

6.4.1 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country: 2019 VS 2023 VS 2030

6.4.2 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2019-2024)

6.4.3 North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2025-2030)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2019-2030)

7.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type

7.2.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2019-2024)

7.2.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2025-2030)

7.2.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2019-2030)

7.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

7.3.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2019-2024)

7.3.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2025-2030)

7.3.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2019-2030)

7.4 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country

7.4.1 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country: 2019 VS 2023 VS 2030

7.4.2 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2019-2024)

7.4.3 Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2025-2030)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2019-2030)

8.2 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type

8.2.1 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2019-2024)

8.2.2 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2025-2030)

8.2.3 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2019-2030)

8.3 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

8.3.1 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2019-2024)

8.3.2 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2025-2030)

8.3.3 China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2019-2030)

9 Asia (excluding China)

9.1 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2019-2030)

9.2 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type

9.2.1 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2019-2024)

9.2.2 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2025-2030)

9.2.3 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2019-2030)

9.3 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

9.3.1 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2019-2024)

9.3.2 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2025-2030)

9.3.3 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2019-2030)

9.4 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region

9.4.1 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region: 2019 VS 2023 VS 2030

9.4.2 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2019-2024)

9.4.3 Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2025-2030)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2019-2030)

10.2 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type

10.2.1 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2019-2024)

10.2.2 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2025-2030)

10.2.3 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2019-2030)

10.3 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application

10.3.1 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2019-2024)

10.3.2 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2025-2030)

10.3.3 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2019-2030)

10.4 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country

10.4.1 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country: 2019 VS 2023 VS 2030

10.4.2 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2019-2024)

10.4.3 Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2025-2030)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Roche (Genentech)

11.1.1 Roche (Genentech) Company Details

11.1.2 Roche (Genentech) Business Overview

11.1.3 Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.1.4 Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.1.5 Roche (Genentech) Recent Developments

11.2 Amgen

11.2.1 Amgen Company Details

11.2.2 Amgen Business Overview

11.2.3 Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.2.4 Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.2.5 Amgen Recent Developments

11.3 B-MS

11.3.1 B-MS Company Details

11.3.2 B-MS Business Overview

11.3.3 B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.3.4 B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.3.5 B-MS Recent Developments

11.4 Merck

11.4.1 Merck Company Details

11.4.2 Merck Business Overview

11.4.3 Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.4.4 Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.4.5 Merck Recent Developments

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.5.4 Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.5.5 Pfizer Recent Developments

11.6 Novartis

11.6.1 Novartis Company Details

11.6.2 Novartis Business Overview

11.6.3 Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.6.4 Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.6.5 Novartis Recent Developments

11.7 Eli Lilly and Company

11.7.1 Eli Lilly and Company Company Details

11.7.2 Eli Lilly and Company Business Overview

11.7.3 Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.7.4 Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.7.5 Eli Lilly and Company Recent Developments

11.8 Johnson & Johnson

11.8.1 Johnson & Johnson Company Details

11.8.2 Johnson & Johnson Business Overview

11.8.3 Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.8.4 Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.8.5 Johnson & Johnson Recent Developments

11.9 GSK

11.9.1 GSK Company Details

11.9.2 GSK Business Overview

11.9.3 GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.9.4 GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.9.5 GSK Recent Developments

11.10 Sanofi

11.10.1 Sanofi Company Details

11.10.2 Sanofi Business Overview

11.10.3 Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.10.4 Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.10.5 Sanofi Recent Developments

11.11 Boehringer Ingelheim

11.11.1 Boehringer Ingelheim Company Details

11.11.2 Boehringer Ingelheim Business Overview

11.11.3 Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.11.4 Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.11.5 Boehringer Ingelheim Recent Developments

11.12 Zhejiang Jiuzhou Pharmaceutical

11.12.1 Zhejiang Jiuzhou Pharmaceutical Company Details

11.12.2 Zhejiang Jiuzhou Pharmaceutical Business Overview

11.12.3 Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Introduction

11.12.4 Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

11.12.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Eli Lilly and Company

Zhejiang Jiuzhou Pharmaceutical

List of Tables

Table 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030

Table 2. Key Players of Aspirin

Table 3. Key Players of Ibuprofen

Table 4. Key Players of Naproxen

Table 5. Key Players of Celecoxib

Table 6. Key Players of Others

Table 7. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030

Table 8. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2019-2024)

Table 11. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2025-2030)

Table 13. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Trends

Table 14. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Drivers

Table 15. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Challenges

Table 16. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Restraints

Table 17. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Players (2019-2024)

Table 19. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2023)

Table 20. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Industry Ranking 2022 VS 2023 VS 2024

Table 21. Global 5 Largest Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (CR5 and HHI) & (2019-2024)

Table 22. Global Key Players of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Headquarters and Area Served

Table 23. Global Key Players of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Product and Application

Table 24. Global Key Players of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Product and Application

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2019-2024)

Table 28. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Type (2025-2030)

Table 30. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Application (2019-2024)

Table 32. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Share by Application (2025-2030)

Table 34. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2019-2024) & (US$ Million)

Table 35. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2025-2030) & (US$ Million)

Table 36. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2019-2024) & (US$ Million)

Table 37. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2025-2030) & (US$ Million)

Table 38. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 39. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2019-2024) & (US$ Million)

Table 40. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2025-2030) & (US$ Million)

Table 41. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2019-2024) & (US$ Million)

Table 42. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2025-2030) & (US$ Million)

Table 43. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2019-2024) & (US$ Million)

Table 44. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2025-2030) & (US$ Million)

Table 45. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2019-2024) & (US$ Million)

Table 47. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2025-2030) & (US$ Million)

Table 48. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2019-2024) & (US$ Million)

Table 49. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2025-2030) & (US$ Million)

Table 50. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2019-2024) & (US$ Million)

Table 51. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2025-2030) & (US$ Million)

Table 52. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2019-2024) & (US$ Million)

Table 53. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2025-2030) & (US$ Million)

Table 54. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2019-2024) & (US$ Million)

Table 55. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2025-2030) & (US$ Million)

Table 56. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030

Table 57. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2019-2024) & (US$ Million)

Table 58. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Region (2025-2030) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2019-2024) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type (2025-2030) & (US$ Million)

Table 61. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2019-2024) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application (2025-2030) & (US$ Million)

Table 63. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030

Table 64. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2019-2024) & (US$ Million)

Table 65. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2025-2030) & (US$ Million)

Table 66. Roche (Genentech) Company Details

Table 67. Roche (Genentech) Business Overview

Table 68. Roche (Genentech) Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 69. Roche (Genentech) Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 70. Roche (Genentech) Recent Developments

Table 71. Amgen Company Details

Table 72. Amgen Business Overview

Table 73. Amgen Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 74. Amgen Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 75. Amgen Recent Developments

Table 76. B-MS Company Details

Table 77. B-MS Business Overview

Table 78. B-MS Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 79. B-MS Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 80. B-MS Recent Developments

Table 81. Merck Company Details

Table 82. Merck Business Overview

Table 83. Merck Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 84. Merck Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 85. Merck Recent Developments

Table 86. Pfizer Company Details

Table 87. Pfizer Business Overview

Table 88. Pfizer Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 89. Pfizer Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 90. Pfizer Recent Developments

Table 91. Novartis Company Details

Table 92. Novartis Business Overview

Table 93. Novartis Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 94. Novartis Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 95. Novartis Recent Developments

Table 96. Eli Lilly and Company Company Details

Table 97. Eli Lilly and Company Business Overview

Table 98. Eli Lilly and Company Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 99. Eli Lilly and Company Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 100. Eli Lilly and Company Recent Developments

Table 101. Johnson & Johnson Company Details

Table 102. Johnson & Johnson Business Overview

Table 103. Johnson & Johnson Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 104. Johnson & Johnson Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 105. Johnson & Johnson Recent Developments

Table 106. GSK Company Details

Table 107. GSK Business Overview

Table 108. GSK Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 109. GSK Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 110. GSK Recent Developments

Table 111. Sanofi Company Details

Table 112. Sanofi Business Overview

Table 113. Sanofi Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 114. Sanofi Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 115. Sanofi Recent Developments

Table 116. Boehringer Ingelheim Company Details

Table 117. Boehringer Ingelheim Business Overview

Table 118. Boehringer Ingelheim Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 119. Boehringer Ingelheim Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 120. Boehringer Ingelheim Recent Developments

Table 121. Zhejiang Jiuzhou Pharmaceutical Company Details

Table 122. Zhejiang Jiuzhou Pharmaceutical Business Overview

Table 123. Zhejiang Jiuzhou Pharmaceutical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Product

Table 124. Zhejiang Jiuzhou Pharmaceutical Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024) & (US$ Million)

Table 125. Zhejiang Jiuzhou Pharmaceutical Recent Developments

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 2. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type: 2023 VS 2030

Figure 3. Aspirin Features

Figure 4. Ibuprofen Features

Figure 5. Naproxen Features

Figure 6. Celecoxib Features

Figure 7. Others Features

Figure 8. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 9. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application: 2023 VS 2030

Figure 10. Drug Store Case Studies

Figure 11. Hospital Pharmacies Case Studies

Figure 12. Online Case Studies

Figure 13. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Report Years Considered

Figure 14. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region: 2023 VS 2030

Figure 17. Global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Players in 2023

Figure 18. Global Top Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Revenue in 2023

Figure 20. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2019-2030)

Figure 22. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2019-2030)

Figure 23. North America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2019-2030)

Figure 24. United States Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Canada Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY (2019-2030) & (US$ Million)

Figure 27. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2019-2030)

Figure 28. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2019-2030)

Figure 29. Europe Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2019-2030)

Figure 30. Germany Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. France Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. U.K. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Italy Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Russia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Nordic Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY (2019-2030) & (US$ Million)

Figure 37. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2019-2030)

Figure 38. China Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2019-2030)

Figure 39. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY (2019-2030) & (US$ Million)

Figure 40. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2019-2030)

Figure 41. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2019-2030)

Figure 42. Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Region (2019-2030)

Figure 43. Japan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. South Korea Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. China Taiwan Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Southeast Asia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. India Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Australia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY (2019-2030) & (US$ Million)

Figure 50. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type (2019-2030)

Figure 51. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application (2019-2030)

Figure 52. Middle East, Africa, and Latin America Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2019-2030)

Figure 53. Brazil Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 54. Mexico Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 55. Turkey Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 56. Saudi Arabia Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 57. Israel Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 58. GCC Countries Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 59. Roche (Genentech) Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 60. Amgen Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 61. B-MS Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 62. Merck Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 63. Pfizer Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 64. Novartis Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 65. Eli Lilly and Company Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 66. Johnson & Johnson Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 67. GSK Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 68. Sanofi Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 69. Boehringer Ingelheim Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 70. Zhejiang Jiuzhou Pharmaceutical Revenue Growth Rate in Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Business (2019-2024)

Figure 71. Bottom-up and Top-down Approaches for This Report

Figure 72. Data Triangulation

Figure 73. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions